clinicalmicrobiologyandinfection.org+2<\/p>\n\n\n\n
Introduction<\/h3>\n\n\n\n
Long COVID refers to persistent or new symptoms occurring after acute SARS-CoV-2 infection, typically lasting at least several weeks to months and not explained by an alternative diagnosis. Population studies have documented substantial long-term morbidity even after non-hospitalized infections, with fatigue, cognitive impairment (\u201cbrain fog\u201d), orthostatic symptoms, palpitations, exercise intolerance, dyspnea, and sleep disturbance among the most common complaints. Dysautonomia has emerged as a recurrent phenotype across Long COVID cohorts, overlapping with conditions such as POTS and myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS).<\/p>\n\n\n\n nature.com+2<\/p>\n\n\n\n The autonomic nervous system (ANS) regulates cardiovascular, respiratory, gastrointestinal, thermoregulatory, endocrine, and immune functions. Because autonomic control is distributed across the brainstem, vagus nerve, sympathetic ganglia, enteric nervous system, endocrine axes, and peripheral sensory networks, disruption at multiple levels can produce the diverse symptom spectrum observed in Long COVID.<\/p>\n\n\n\n pmc.ncbi.nlm.nih.gov+2<\/p>\n\n\n\n Many patients with Long COVID exhibit evidence of ongoing immune perturbation months after acute infection, including altered cytokine profiles, activated immune-cell subsets, and inflammatory mediators. These signals may affect autonomic control through both central and peripheral pathways. The vagus nerve normally participates in the \u201ccholinergic anti-inflammatory pathway,\u201d in which vagal efferent signaling modulates inflammatory responses. Impairment of this pathway has been proposed as a contributor to persistent symptoms.<\/p>\n\n\n\n clinicalmicrobiologyandinfection.org+2<\/p>\n\n\n\n Autoantibodies directed against G-protein\u2013coupled receptors (GPCRs), including adrenergic and muscarinic receptors, have been reported in subsets of patients with POTS and Long COVID. These antibodies may alter autonomic signaling, vascular tone, and heart-rate regulation, although causality remains under investigation.<\/p>\n\n\n\n pmc.ncbi.nlm.nih.gov<\/p>\n\n\n\n Small unmyelinated and thinly myelinated fibers carry autonomic as well as sensory signals. Small-fiber injury can produce orthostatic intolerance, abnormal sweating, gastrointestinal dysmotility, neuropathic pain, and temperature dysregulation. Several Long COVID cohorts have demonstrated findings consistent with small-fiber neuropathy in at least a subset of patients.<\/p>\n\n\n\n pmc.ncbi.nlm.nih.gov+1<\/p>\n\n\n\n SARS-CoV-2 can affect vascular and endothelial pathways during acute infection, and persistent endothelial dysfunction has been proposed as a mechanism for impaired perfusion, exercise intolerance, and autonomic symptoms. Microvascular abnormalities may interact with autonomic dysfunction by impairing cerebral and peripheral blood-flow regulation.<\/p>\n\n\n\n nature.com+1<\/p>\n\n\n\n The central autonomic network includes the nucleus tractus solitarius (NTS), dorsal motor nucleus of the vagus, hypothalamus, insula, amygdala, anterior cingulate cortex, and brainstem autonomic nuclei. Neuroinflammation, altered connectivity, or injury within these regions could contribute to dysautonomia, fatigue, cognitive dysfunction, and neuropsychiatric symptoms.<\/p>\n\n\n\n mdpi.com+2<\/p>\n\n\n\n The vagus nerve (cranial nerve X) provides extensive parasympathetic innervation to the heart, lungs, gastrointestinal tract, liver, pancreas, and other organs. Approximately 80% of its fibers are afferent, transmitting sensory information from visceral organs to the brainstem. Through the NTS and related circuits, vagal afferents influence autonomic balance, respiration, satiety, inflammation, mood, and neuroendocrine function.<\/p>\n\n\n\n clinicalmicrobiologyandinfection.org+1<\/p>\n\n\n\n Cardiovascular<\/p>\n\n\n\n Respiratory<\/p>\n\n\n\n Gastrointestinal<\/p>\n\n\n\n Neurocognitive & endocrine-immune<\/p>\n\n\n\n Vagal dysfunction could affect cardiovascular, respiratory, gastrointestinal, neurocognitive, and endocrine-immune domains through reduced parasympathetic tone, impaired baroreflexes, altered respiratory control, enteric dysregulation, and disrupted cholinergic anti-inflammatory signaling.<\/p>\n\n\n\n Vagal dysfunction has been hypothesized to reduce anti-inflammatory signaling and mitochondrial efficiency, potentially amplifying fatigue, cognitive symptoms, and autonomic instability.<\/p>\n\n\n\n frontiersin.org+1<\/p>\n\n\n\n Because vagal afferents communicate with the hypothalamus and brainstem, vagal dysfunction may influence stress-hormone regulation, appetite signaling, glucose homeostasis, and other endocrine processes. Proposed effects include altered cortisol dynamics, disrupted autonomic\u2013immune\u2013endocrine coupling, and changes in satiety and metabolic signaling, although these relationships remain incompletely defined.<\/p>\n\n\n\n mdpi.com+1<\/p>\n\n\n\n Common manifestations include:<\/p>\n\n\n\n Orthostatic symptoms<\/p>\n\n\n\n Cardiovascular dysautonomia<\/p>\n\n\n\n Sudomotor and thermoregulatory<\/p>\n\n\n\n Gastrointestinal and neurocognitive<\/p>\n\n\n\n Long-COVID dysautonomia often presents as overlapping orthostatic, cardiovascular, sudomotor, thermoregulatory, gastrointestinal, and neurocognitive symptom clusters.<\/p>\n\n\n\n Long-COVID dysautonomia frequently overlaps with ME\/CFS-like post-exertional malaise and impaired recovery after physical or cognitive exertion.<\/p>\n\n\n\n nature.com+2<\/p>\n\n\n\n A structured H&P is essential because symptoms are multisystemic and often fluctuate. Key history elements include:<\/p>\n\n\n\n Formal autonomic testing may include tilt-table testing, HRV analysis, Valsalva maneuver, deep-breathing tests, sudomotor testing, and quantitative sensory testing. Recent studies have documented abnormalities in standing responses, HRV, and baroreflex-related measures in Long COVID cohorts.<\/p>\n\n\n\n jacc.org+2<\/p>\n\n\n\n A recurring finding is reduced parasympathetic activity and\/or excessive sympathetic activation, reflected by impaired HRV and exaggerated heart-rate responses. Reduced respiratory sinus arrhythmia and abnormal Valsalva responses have been observed in some Long COVID patients.<\/p>\n\n\n\n jacc.org+1<\/p>\n\n\n\n Baroreceptors maintain blood-pressure stability during postural change. Impaired baroreflex sensitivity can contribute to orthostatic tachycardia, dizziness, and exercise intolerance.<\/p>\n\n\n\n jacc.org+1<\/p>\n\n\n\n Vagal afferent signaling normally helps coordinate immune responses. Disruption of vagal pathways may weaken anti-inflammatory regulation, contributing to persistent symptoms.<\/p>\n\n\n\n frontiersin.org+1<\/p>\n\n\n\n Impaired tissue perfusion, endothelial dysfunction, and altered cellular energy metabolism have been proposed as contributors to fatigue and exercise intolerance, though the relative importance of each mechanism remains under investigation.<\/p>\n\n\n\n nature.com+1<\/p>\n\n\n\n Long COVID follows heterogeneous trajectories. Some patients improve gradually over months, while others experience persistent or relapsing symptoms. Orthostatic intolerance, fatigue, and cognitive symptoms may fluctuate with activity level, stress, infection, heat exposure, and sleep quality. Longitudinal studies suggest that a substantial proportion of symptomatic individuals remain symptomatic at one year or longer.<\/p>\n\n\n\n nature.com<\/p>\n\n\n\n Risk factors for prolonged symptoms are still being clarified but may include greater acute illness burden, female sex, preexisting autonomic vulnerability, autoimmune predisposition, and repeated infections.<\/p>\n\n\n\n nature.com+1<\/p>\n\n\n\n Volume expansion<\/p>\n\n\n\n Compression & orthostatic countermeasures<\/p>\n\n\n\n Activity pacing<\/p>\n\n\n\n Physical rehabilitation<\/p>\n\n\n\n Initial management usually emphasizes hydration, sodium and volume support, compression garments, pacing, and carefully titrated rehabilitation before considering medications.<\/p>\n\n\n\n These approaches are commonly recommended for orthostatic intolerance and POTS-like presentations and should be individualized to symptom pattern and comorbidities.<\/p>\n\n\n\n pmc.ncbi.nlm.nih.gov+2<\/p>\n\n\n\n Evidence remains limited and largely extrapolated from POTS and dysautonomia literature. Depending on the phenotype, clinicians may consider:<\/p>\n\n\n\n Therapy should be individualized and monitored for adverse effects. Current reviews emphasize that high-quality randomized evidence for Long COVID dysautonomia remains limited.<\/p>\n\n\n\n pubmed.ncbi.nlm.nih.gov<\/p>\n\n\n\n Interest in vagus-nerve stimulation has increased because of its potential effects on autonomic balance, inflammation, pain, mood, and cognition. Non-invasive transcutaneous vagus-nerve stimulation (tVNS) stimulates auricular branches of the vagus nerve through the skin of the ear. Early pilot studies have reported improvements in some Long COVID symptoms, including fatigue and autonomic complaints, but the evidence remains preliminary and requires confirmation in larger randomized trials.<\/p>\n\n\n\n pmc.ncbi.nlm.nih.gov+2<\/p>\n\n\n\n Vagus-nerve stimulation is biologically plausible and under active investigation, but it should currently be viewed as an emerging rather than established therapy.<\/p>\n\n\n\n Because VNS is not yet standard therapy for Long COVID, clinicians should frame it as investigational and consider trial enrollment when appropriate.<\/p>\n\n\n\n VNS for Long-COVID-19+1<\/p>\n\n\n\n Long COVID lacks a single diagnostic biomarker. Dysautonomia can be intermittent and may not be captured during a brief clinic visit. Symptom overlap with anxiety disorders, deconditioning, cardiac disease, endocrine disorders, and primary autonomic disorders requires careful evaluation. Objective measures such as orthostatic vital signs, tilt-table testing, HRV analysis, and validated symptom questionnaires can improve diagnostic confidence.<\/p>\n\n\n\n medrxiv.org+2<\/p>\n\n\n\n Key research priorities include:<\/p>\n\n\n\n Long COVID\u2013associated dysautonomia represents a clinically significant and mechanistically complex disorder involving autonomic, immune, vascular, neurologic, and endocrine systems. Current evidence supports a multifactorial model that includes autonomic imbalance, baroreflex dysfunction, small-fiber neuropathy, immune dysregulation, and possible vagal-pathway impairment. The vagus nerve occupies a central position linking inflammation, cardiovascular control, respiration, gastrointestinal function, and neuroendocrine signaling, making it an attractive but still investigational therapeutic target. Evaluation requires a structured history, orthostatic assessment, and selective autonomic testing. Management currently relies on symptom-directed strategies\u2014hydration, salt loading when appropriate, compression garments, pacing, tailored rehabilitation, and selected medications\u2014with emerging interest in non-invasive vagus-nerve stimulation. While substantial progress has been made, rigorous mechanistic studies and randomized clinical trials remain essential to define causal pathways and establish effective treatments.<\/p>\n\n\n\n clinicalmicrobiologyandinfection.org+3<\/p>\n\n\n\n John Murphy, M.D., M.P.H., D.P.H., President, The COVID-19 Lonh-haul Foundation Abstract: Long COVID (post-acute sequelae of SARS-CoV-2 infection, PASC) is increasingly recognized as a heterogeneous syndrome characterized by persistent fatigue, […]<\/p>\n","protected":false},"author":2,"featured_media":15310,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[94,756,129,990,169,416,452,949,566,611],"tags":[],"class_list":["post-15130","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cognitive-deficit","category-cognitive-deficits","category-dysautonomia","category-dyspnea","category-fatigure","category-pain","category-postural-orthostatic-tachycardia-pots","category-sleep-disturbance","category-tachycardia","category-vagus-nerve"],"_links":{"self":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/15130","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15130"}],"version-history":[{"count":1,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/15130\/revisions"}],"predecessor-version":[{"id":15131,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/15130\/revisions\/15131"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/media\/15310"}],"wp:attachment":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15130"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15130"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15130"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}<\/figure>\n\n\n\n
<\/figure>\n\n\n\n
<\/figure>\n\n\n\n
<\/figure>\n\n\n\n
<\/figure>\n\n\n\n
<\/figure>\n\n\n\n
Etiology and Pathogenesis<\/h3>\n\n\n\n
Persistent immune activation and inflammatory signaling<\/h3>\n\n\n\n
<\/figure>\n\n\n\n
Autoimmunity and receptor-targeting antibodies<\/h3>\n\n\n\n
<\/figure>\n\n\n\n
Small-fiber neuropathy<\/h3>\n\n\n\n
<\/figure>\n\n\n\n
Endothelial dysfunction and microvascular injury<\/h3>\n\n\n\n
<\/figure>\n\n\n\n
Central autonomic network involvement<\/h3>\n\n\n\n
<\/figure>\n\n\n\n
Vagus Nerve: Anatomy, Physiology, and Long-COVID Implications<\/h3>\n\n\n\n
<\/figure>\n\n\n\n
Potential consequences of vagal dysfunction in Long COVID<\/h3>\n\n\n\n
\n
\n
\n
\n
<\/figure>\n\n\n\n
Effects on hormones and neuroendocrine systems<\/h3>\n\n\n\n
<\/figure>\n\n\n\n
Clinical Phenotypes of Long-COVID Dysautonomia<\/h3>\n\n\n\n
Typical symptom clusters<\/h3>\n\n\n\n
\n
\n
\n
\n
<\/figure>\n\n\n\n
History and Physical Examination (H&P) Collection<\/h3>\n\n\n\n
History<\/h3>\n\n\n\n
\n
\n
\n
\n
\n
\n
\n
Physical examination<\/h3>\n\n\n\n
\n
<\/figure>\n\n\n\n
Pathology and Physiology<\/h3>\n\n\n\n
Autonomic imbalance<\/h3>\n\n\n\n
<\/figure>\n\n\n\n
Baroreflex impairment<\/h3>\n\n\n\n
<\/figure>\n\n\n\n
Neuroimmune dysregulation<\/h3>\n\n\n\n
<\/figure>\n\n\n\n
Microvascular and mitochondrial considerations<\/h3>\n\n\n\n
<\/figure>\n\n\n\n
Disease Progression and Prognosis<\/h3>\n\n\n\n
<\/figure>\n\n\n\n
<\/figure>\n\n\n\n
Treatment Strategies<\/h3>\n\n\n\n
Nonpharmacologic foundations<\/h3>\n\n\n\n
\n
\n
\n
\n
<\/figure>\n\n\n\n
Pharmacologic management<\/h3>\n\n\n\n
Strategy<\/td> Potential role<\/td><\/tr><\/thead> Beta-blockers<\/td> Reduce tachycardia and palpitations.<\/td><\/tr> Ivabradine<\/td> Heart-rate control in selected patients.<\/td><\/tr> Fludrocortisone<\/td> Volume expansion for orthostatic intolerance.<\/td><\/tr> Midodrine<\/td> Increase vascular tone for orthostatic hypotension.<\/td><\/tr> Pyridostigmine<\/td> Enhance parasympathetic signaling in some dysautonomia phenotypes.<\/td><\/tr> Neuropathic pain agents<\/td> Target small-fiber neuropathy symptoms.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n <\/figure>\n\n\n\n
Vagus-nerve\u2013targeted interventions<\/h3>\n\n\n\n
<\/figure>\n\n\n\n
What is known about vagus-nerve stimulation (VNS)?<\/h3>\n\n\n\n
Domain<\/td> Current evidence<\/td><\/tr><\/thead> Mechanistic rationale<\/td> May increase parasympathetic tone and engage the cholinergic anti-inflammatory pathway. pmc.ncbi.nlm.nih.gov+1<\/td><\/tr>
Pilot studies<\/td> Small studies have reported symptom improvement in subsets of Long COVID patients. pmc.ncbi.nlm.nih.gov+1<\/td><\/tr>
Ongoing trials<\/td> Randomized and sham-controlled studies are underway. VNS for Long-COVID-19<\/td><\/tr>
Clinical takeaway<\/td> Promising but not yet established as standard care; larger trials are needed before routine recommendation. VNS for Long-COVID-19+1<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
<\/figure>\n\n\n\n
Vagal Dysfunction and Organ-System Effects<\/h3>\n\n\n\n
Cardiovascular<\/h3>\n\n\n\n
\n
jacc.org+1<\/li>\n<\/ul>\n\n\n\n
Respiratory<\/h3>\n\n\n\n
\n
pmc.ncbi.nlm.nih.gov+1<\/li>\n<\/ul>\n\n\n\n
Gastrointestinal<\/h3>\n\n\n\n
\n
clinicalmicrobiologyandinfection.org+1<\/li>\n<\/ul>\n\n\n\n
Neuroendocrine and immune<\/h3>\n\n\n\n
\n
mdpi.com+1<\/li>\n<\/ul>\n\n\n\n
Diagnostic Challenges<\/h3>\n\n\n\n
<\/figure>\n\n\n\n
Future Directions<\/h3>\n\n\n\n
\n
VNS for Long-COVID-19+2<\/li>\n<\/ol>\n\n\n\n
Conclusion<\/h3>\n\n\n\n
<\/figure>\n\n\n\n
Selected References<\/h3>\n\n\n\n
\n
clinicalmicrobiologyandinfection.org+1<\/li>\n\n\n\n
pmc.ncbi.nlm.nih.gov<\/li>\n\n\n\n
nature.com<\/li>\n\n\n\n
jacc.org<\/li>\n\n\n\n
pmc.ncbi.nlm.nih.gov<\/li>\n\n\n\n
nature.com<\/li>\n\n\n\n
pmc.ncbi.nlm.nih.gov+1<\/li>\n\n\n\n
pmc.ncbi.nlm.nih.gov+1<\/li>\n\n\n\n
VNS for Long-COVID-19<\/li>\n\n\n\n
mdpi.com<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"